Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$13,044 | -$10,752 | -$9,497 |
| Dep. & Amort. | $0 | $417 | $406 | $401 |
| Deferred Tax | $0 | $0 | -$2,258 | -$3,813 |
| Stock-Based Comp. | $0 | $0 | $1,517 | $1,288 |
| Change in WC | $3,537 | -$5,616 | $132 | -$1,695 |
| Other Non-Cash | -$11,093 | $1,292 | $2,258 | $3,799 |
| Operating Cash Flow | -$7,556 | -$16,951 | -$8,698 | -$9,517 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38 | -$8 | -$37 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$38 | -$8 | -$37 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $3,000 | -$92 | -$78 | -$71 |
| Stock Issued | $12,238 | $19,106 | $903 | $13,322 |
| Stock Repurch. | -$530 | -$1,064 | $0 | -$831 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$61 | $0 | $0 | $0 |
| Financing Cash Flow | $14,647 | $17,950 | $825 | $12,420 |
| Forex Effect | $0 | $0 | $0 | $13 |
| Net Chg. in Cash | $7,053 | $991 | -$7,910 | $2,949 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,451 | $8,460 | $16,370 | $13,422 |
| End Cash | $16,504 | $9,451 | $8,460 | $16,370 |
| Free Cash Flow | -$7,594 | -$16,959 | -$8,735 | -$9,520 |